Exponent, Inc. EXPO
Regular-session close
After hours · Nov 16, 4:39 PM ET
- YTD
- +26.95%
- 1 year
- +26.08%
- Market cap
- 4.19B
- Revenue (ttm)
- 583.12M
- Profit margin
- 19.67%
- EPS (ttm)
- 2.32
- Shares out
- 47.55M
- P/E ratio
- 38.01
- Forward P/E
- 30.21
- Dividend
- 1.24 (1.42%)
- Ex-dividend date
- Dec 4, 2026
- YTD return
- +26.95%
- 1-year return
- +26.08%
- Volume
- 341.84K
- Avg volume
- 511.28K
- Open
- 87.82
- Previous close
- 87.31
- Day's range
- 87.60 – 88.72
- 52-week range
- 51.91 – 90.51
- Beta
- 0.68
- Price target
- 90.67 (+2.8%)
- Earnings date
- Feb 4, 2027
- 50-day average
- 73.30
- 200-day average
- 67.16
Key statistics
- Enterprise value
- 4.12B
- PEG ratio
- 2.03
- Price / sales
- 7.19
- Price / book
- 13.62
- Payout ratio
- 53.02%
- Revenue growth
- 11.70%
- Free cash flow
- 115.88M
- Total cash
- 114.69M
- Total debt
- 81.14M
- Return on equity
- 32.27%
- Short % of float
- 6.80%
Fundamental scorecard
20 of 25 checks passed on EXPO’s reported financials
20of 25 checks passed
- Value 2 of 5
- Growth 5 of 5
- Profitability 4 of 5
- Financial health 5 of 5
- Dividend 4 of 5
Statements to Oct 2, 2026.
Analyst view
- Target (low)
- 82.00
- Target (mean)
- 90.67
- Target (high)
- 100.00
- Strong buy1
- Buy2
- Hold1
- Sell0
- Strong sell0
Next earnings
Feb 4, 2027
Expected Feb 4, 2027. Consensus EPS estimate 0.57139.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 4, 2027 | Jan 2, 2027 | 0.53 | — | — | — |
| Oct 29, 2026 | Oct 2, 2026 | 0.596 | 0.64 | +0.04 | +7.38% |
| Jul 30, 2026 | Jul 3, 2026 | 0.549 | 0.60 | +0.05 | +9.29% |
| Apr 30, 2026 | Apr 3, 2026 | 0.56 | 0.59 | +0.03 | +5.36% |
| Feb 5, 2026 | Jan 2, 2026 | 0.47 | 0.49 | +0.02 | +4.26% |
| Oct 30, 2025 | Oct 3, 2025 | 0.50 | 0.55 | +0.05 | +10.00% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | UBS | main | Neutral | Neutral |
| Oct 30, 2026 | JP Morgan | main | Overweight | Overweight |
| Jul 31, 2026 | UBS | main | Neutral | Neutral |
| Jul 31, 2026 | JP Morgan | main | Overweight | Overweight |
| May 15, 2026 | JP Morgan | main | Overweight | Overweight |
| May 1, 2026 | UBS | main | Neutral | Neutral |
About Exponent, Inc.
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. It provides services in the areas of biomechanics, biomedical engineering and sciences, civil and structural engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, metallurgical and corrosion engineering polymer and chemistry, thermal sciences, and vehicle engineering. The company also offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. In addition, it provides proactive and reactive product safety, litigation support, and technical, regulatory services. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. The company was founded in 1967 and is headquartered in Menlo Park, California.
- Sector
- Industrials
- Industry
- Engineering & Construction
- Country
- United States
- Website
- exponent.com
News
Your note
Sign in to keep a note on EXPO — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BROWN GEORGE H | Director | Conversion of Exercise of derivative security | Jun 2, 2026 | 10,730 |
| CORRIGAN CATHERINE FORD | Chief Executive Officer | Sale | Aug 16, 2026 | 129,108 |
| JAMES BRADLEY A | Officer | Sale | May 25, 2026 | 1,105 |
| JOHNSTON PAUL R | Director | Conversion of Exercise of derivative security | Jun 2, 2026 | 62,940 |
| LINDSTROM CAROL J | Director | Conversion of Exercise of derivative security | Jun 2, 2026 | 9,405 |
| PYE JOHN | Officer | Conversion of Exercise of derivative security | Mar 10, 2026 | 29,131 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 13.06% | 6,208,315 | 547.45M | Sep 29, 2026 |
| Kayne Anderson Rudnick Investment Management LLC | 6.93% | 3,294,237 | 290.49M | Sep 29, 2026 |
| Vanguard Portfolio Management LLC | 6.50% | 3,090,237 | 272.50M | Sep 29, 2026 |
| Vanguard Capital Management LLC | 4.42% | 2,100,717 | 185.24M | Sep 29, 2026 |
| State Street Corporation | 4.12% | 1,957,574 | 172.62M | Sep 29, 2026 |
| Geode Capital Management, LLC | 3.72% | 1,770,317 | 156.11M | Sep 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.56% | 1,691,812 | 149.18M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.23% | 1,538,230 | 135.64M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.67% | 1,270,818 | 112.06M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.33% | 1,109,114 | 97.80M | Jun 29, 2026 |
| First TRT Exch-Trd Fd. VI-First TRT SMID Cap Rising Dividend Achievers | 2.25% | 1,071,807 | 94.51M | Sep 29, 2026 |
| GLOBAL X FUNDS-Global X US Infrastructure Development ETF | 1.54% | 732,404 | 64.58M | Sep 29, 2026 |
